各国经导管主动脉瓣植入候选者年数量:当前估计与未来预测
本研究通过系统文献检索和荟萃分析,结合人口统计学数据和蒙特卡洛模拟,估计了27个欧洲国家、美国和加拿大当前及未来的年度TAVI候选者数量。若适应证扩展至低危患者,可能增至27万例。
要点
- 欧洲和北美每年约有18万例潜在TAVI候选者
- 若TAVI适应证扩展至低危患者,候选者数量可能增至27万例
- 严重症状性AS患者中41.6%未接受外科主动脉瓣置换
核心结论
- 目前欧盟和北美每年约有18万患者可被视为潜在TAVI候选者,若适应证扩展至低危患者可能增至27万例。
研究设计与样本
- 对主动脉瓣狭窄流行病学和严重症状性AS决策制定进行系统文献检索和荟萃分析,结合人口统计学数据,采用蒙特卡洛模拟预测年度TAVI候选者数量。
主要发现
- 年龄≥65岁患者严重AS年发病率为4.4‰(95%CI 3.0-6.1‰)。
- 严重AS患者中68.3%(95%CI 60.8-75.9%)存在AS相关症状。
- 尽管有严重症状性AS,41.6%(95%CI 36.9-46.3%)未接受外科主动脉瓣置换。
- 未手术患者中61.7%(95%CI 42.0-81.7%)接受了TAVI。
临床怎么用
- 研究结果可用于29个国家的医疗资源规划,以应对TAVI需求增长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The number of transcatheter aortic valve implantation (TAVI) procedures is rapidly increasing. This has a major impact on health care resource planning. However, the annual numbers of TAVI candidates per country are unknown. The aim of this study was to estimate current and future number of annual TAVI candidates in 27 European countries, the USA and Canada. METHODS AND RESULTS: Systematic literature searches and meta-analyses were performed on aortic stenosis (AS) epidemiology and decision-making in severe symptomatic AS. The incidence rate of severe AS was determined. Findings were combined with population statistics and integrated into a model employing Monte Carlo simulations to predict the annual number of TAVI candidates. Various future scenarios and sensitivity analyses were explored. Data from 37 studies (n = 26 402) informed the model. The calculated incidence rate of severe AS was 4.4‰/year [95% confidence interval (95% CI) 3.0-6.1‰] in patients ≥65 years. AS-related symptoms were present in 68.3% (95% CI 60.8-75.9%) of patients with severe AS. Despite having severe symptomatic AS, 41.6% (95% CI 36.9-46.3%) did not undergo surgical aortic valve replacement. Of the non-operated patients, 61.7% (95% CI 42.0-81.7%) received TAVI. The model predicted 114 757 (95% CI 69 380-172 799) European and 58 556 (95% CI 35 631-87 738) Northern-American TAVI candidates annually. CONCLUSION: Currently, approximately 180 000 patients can be considered potential TAVI candidates in the European Union and in Northern-America annually. This number might increase up to 270 000 if indications for TAVI expand to low-risk patients. These findings have major implications for health care resource planning in the 29 individual countries.
引用
- Durko AP, Osnabrugge RL, Van Mieghem NM, et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J. 2018. PMID: 29546396. doi:10.1093/eurheartj/ehy107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。